Dysfagia po udarach mózgu – wskazówki diagnostyczne i terapeutyczne

by Tatiana Lewicka, Ewa Krzystanek
Published 2017-12-01

Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity

by Marek Krzystanek, Ewa Krzystanek, Katarzyna Skałacka, Artur Pałasz
Published 2020-12-01

A 50-Year-Old Patient with Guillain–Barré Syndrome after COVID-19: A Case Report

by Tomasz Chmiela, Michalina Rzepka, Ewa Krzystanek, Agnieszka Gorzkowska
Published 2021-07-01

Relationship between Fatigue and Physical Activity in a Polish Cohort of Multiple Sclerosis Patients

by Michalina Rzepka, Mateusz Toś, Michał Boroń, Katarzyna Gibas, Ewa Krzystanek
Published 2020-12-01

The Impact of Vitamin D Low Doses on Its Serum Level and Cytokine Profile in Multiple Sclerosis Patients

by Anna Walawska-Hrycek, Weronika Galus, Eugeniusz Hrycek, Aleksandra Kaczmarczyk, Ewa Krzystanek
Published 2021-06-01

Adequate Knowledge of Stroke Symptoms, Risk Factors, and Necessary Actions in the General Population of Southern Poland

by Ewa Krzystanek, Agnieszka Krzak-Kubica, Maciej Świat, Weronika Galus, Justyna Gawryluk
Published 2020-12-01

Kinesiophobia in Stroke Patients, Multiple Sclerosis and Parkinson’s Disesase

by Dagmara Wasiuk-Zowada, Andrzej Knapik, Justyna Szefler-Derela, Anna Brzęk, Ewa Krzystanek
Published 2021-04-01

Effectiveness of 6-Week Nordic Walking Training on Functional Performance, Gait Quality, and Quality of Life in Parkinson’s Disease

by Justyna Szefler-Derela, Michal Arkuszewski, Andrzej Knapik, Dagmara Wasiuk-Zowada, Agnieszka Gorzkowska, Ewa Krzystanek
Published 2020-07-01

Affective Disorder and Functional Status as well as Selected Sociodemographic Characteristics in Patients with Multiple Sclerosis, Parkinson’s Disease and History of Stroke

by Andrzej Knapik, Ewa Krzystanek, Justyna Szefler–Derela, Joanna Siuda, Jerzy Rottermund, Ryszard Plinta, Anna Brzęk
Published 2020-03-01

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients

by Anna Jamroz-Wiśniewska, Radosław Zajdel, Agnieszka Słowik, Monika Marona, Marcin Wnuk, Monika Adamczyk-Sowa, Bożena Adamczyk, Anetta Lasek-Bal, Przemysław Puz, Arkadiusz Stęposz, Ewa Krzystanek, Maja Patalong-Ogiewa, Anna Pokryszko-Dragan, Sławomir Budrewicz, Dorota Koziarska, Anna Karbicka, Sławomir Wawrzyniak, Waldemar Fryze, Marzena Furtak-Niczyporuk, Konrad Rejdak
Published 2021-04-01